<img src="https://www.bostonherald.com/wp-content/uploads/2018/11/HeraldDotComBanner.svg" alt="Boston Herald">

Pfizer will release its fourth-quarter earnings next month, and analysts anticipate a low double-digit profit dip.

Topics Economy

Pfizer's Quarterly Earnings Preview: What You Need to Know

Today 6:43 EST

Via Barchart.com

Topics Intellectual Property

5 of the Safest Ultra-High-Yield Dividend Stocks You Can Confidently Buy for 2026 ↗

Today 4:11 EST

Five sensational income stocks -- sporting yields ranging from 5.3% to 13.1% -- can fatten investors' pocketbooks in the new year.

There were nice companies and great CEOs in 2025, but also some duds. We discuss the stocks on each list and end by going shopping for stocks.

Topics Bonds

Motley Fool Money: Stock Market Naughty and Nice List ↗

Today 0:53 EST

Hims & Hers Enters 2026 On Solid Ground — Stock Rises Even After Novo Nordisk Leaves It Off Wegovy Partner List ↗

Topics Artificial Intelligence

January 05, 2026

The development comes as attention remains on Hims’ longer-term business expansion initiatives.

Via Stocktwits

2 S&P 500 Stocks with Competitive Advantages and 1 We Avoid

January 05, 2026

While the S&P 500 (^GSPC) includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural...

Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 17.2% over...

Topics Stocks

1 Healthcare Stock to Target This Week and 2 We Turn Down

January 05, 2026

Move comes in response to a presidential memorandum issued by President Donald Trump in December, aimed at aligning U.S. vaccination practices with other developed nations.

Topics Stocks

U.S. Scales Back The Number Of Vaccines It Recommends For Every Child ↗

January 05, 2026

Via Stocktwits

Topics Government

Flu Season's Here—This Dividend-Payer Controls the Shot Market ↗

January 05, 2026

Via MarketBeat

Topics Artificial Intelligence Death

Looking for the most active stocks in the S&P500 index on Monday? ↗

January 05, 2026

Via Chartmill

This Flying-Under-the-Radar Pharma Stock Pays Nearly 7% (While Everyone's Sleeping) ↗

January 05, 2026

Investors seem to be underestimating this company's foreseeable future.

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

These 3 Stocks Trade at Discounts the Market Won’t Ignore Forever ↗

January 05, 2026

Via MarketBeat

January 05, 2026

From Pfizer Inc.

Via Business Wire

Is It Time to Dump Your Shares of Eli Lilly? ↗

January 05, 2026

Eli Lilly has the lead in the GLP-1 race, but Novo Nordisk just changed the game.

Both Ford and Pfizer have very attractive dividend yields.

Better Dividend Stock: Ford vs. Pfizer ↗

January 05, 2026

Another year, another long list of great dividend stocks.

Topics Economy Electric Vehicles Government

26 Top Dividend Stocks to Buy and Hold in 2026 ↗

January 05, 2026

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Topics Intellectual Property

3 Stocks Under $50 with Questionable Fundamentals

January 04, 2026

Income investors probably don't need to worry about a dividend cut from Pfizer in the new year.

How Safe Is Pfizer's Dividend As 2026 Begins? ↗

January 03, 2026

The company's prospects are stronger than its stock-market performance in 2025 suggests.

2 Predictions for Pfizer in 2026 ↗

January 02, 2026

Momentum in Healthcare and Banking to Persist in 2026 as AstraZeneca and Citigroup Lead the Charge

Topics Intellectual Property

January 02, 2026

As the global markets open for the first week of 2026, a clear narrative has emerged: the "recovery plays" of 2025 have officially transformed into the "expansion leaders" of the new year. Following a...

The 2026 Pharma Reset: How Industry Giants Are Navigating a New Era of Federal Price Controls

Topics Artificial Intelligence Economy Initial Public Offering

January 02, 2026

Yesterday marked the official commencement of the first-ever "Maximum Fair Prices" (MFPs) for ten of the most widely used drugs in the Medicare program, a direct result of the Inflation Reduction Act’s...

As the calendar turns to 2026, Alnylam Pharmaceuticals (Nasdaq: ALNY) stands at the threshold of a new era. Once a speculative pioneer in the arcane world of RNA interference (RNAi), the...

Topics Economy Intellectual Property World Trade

The RNAi Powerhouse: A Deep Dive into Alnylam Pharmaceuticals’ Path to the S&P 500

January 02, 2026

Via PredictStreet

Topics Economy Intellectual Property Stocks

The Great Rebound: US M&A Poised for Record-Breaking 2026 as Interest Rates Stabilize

January 01, 2026

As the calendar turns to January 1, 2026, the United States financial markets are witnessing a dramatic transformation in the landscape of corporate dealmaking. After a multi-year "deal desert"...

Pfizer’s Dividend Trap or Deep Value? Analyzing the Pharma Giant as Shares Languish Below $30

Topics Artificial Intelligence Economy

January 01, 2026

As the calendar turns to January 1, 2026, Pfizer Inc. (NYSE: PFE) finds itself in a position that would have been unthinkable during the height of the pandemic. Once the darling of the pharmaceutical...

Economic Revolution or Looming Recession? Trump’s ‘A++’ Claims Clash with Wall Street’s Cautious 2026 Outlook

Topics Intellectual Property

January 01, 2026

As the sun rises on January 1, 2026, the United States finds itself at a historical crossroads, caught between the triumphant rhetoric of an "Economic Revolution" and the sobering data of a cooling...

It might not pay off immediately, but it could, eventually.

Topics Artificial Intelligence Economy Government

Should You Buy Pfizer While It's Under $30? ↗

January 01, 2026

Investing $122,100 in These 3 High-Yield Dividend Stocks Could Make You $10,000 in Reliable Passive Income in 2026 ↗

Topics Government Intellectual Property World Trade

January 01, 2026

The money could flow in with these great dividend stocks.

The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant...

1 Momentum Stock to Target This Week and 2 That Underwhelm

December 31, 2025

Pfizer's stock is down roughly 60% from its late 2021 highs, but the drug giant is working to innovate its way back into the big leagues.

Where Will Pfizer Be in 5 Years? ↗

December 31, 2025

The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings

Topics Intellectual Property

December 31, 2025

As 2025 draws to a close, the pharmaceutical industry stands at a historic crossroads. The year was defined by a widening chasm between the "metabolic haves"—those profiting from the global obesity...